Taylor Devices, Inc. (TAYD) - Q1 2026 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Taylor Devices, Inc., covering the three-month period ended August 31, 2025. The company designs, manufactures, and sells precision mechanical components and assemblies, primarily for the aerospace/defense, structural, and industrial sectors. The company is classified as a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q1 2026 (Ended Aug 31, 2025) | Q1 2025 (Ended Aug 31, 2024) |
|---|---|---|
| Net Sales | $9,918,350 | $11,617,856 |
| Gross Profit | $4,438,744 | $5,503,630 |
| Gross Margin | 44.7% | 47.4% |
| Operating Income | $2,245,267 | $2,904,901 |
| Net Income | $2,190,084 | $2,666,655 |
| Diluted EPS | $0.70 | $0.85 |
| Cash & Equivalents | $2,153,006 | $2,163,496 (End of Q1 2025) |
| Short-term Investments | $34,151,464 | N/A (Prior period not explicitly stated in balance sheet comparison) |
| Backlog | $27.9 million | $28.4 million (Aug 31, 2024) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased by 15% ($1.7 million) compared to the prior year. This was driven by a 23% drop in revenue from long-term projects and a 44% decrease in sales to Asia. Sales to aerospace/defense customers fell 26%, while construction-related sales increased 11%.
- Profitability: Net income decreased 18% ($477,000). Gross margin compressed by 2 percentage points to 45% due to the revenue mix and volume.
- Expense Management: Selling, general, and administrative (SG&A) expenses decreased 16% ($417,000), primarily due to lower employee incentive compensation accruals. R&D costs increased slightly by 17% ($12,000).
- Liquidity: Cash and cash equivalents increased by $962,350 during the quarter, driven by a net cash inflow from operating activities of $483,628 and investing activities of $461,824 (largely from the decrease in short-term investments).
- Working Capital: Accounts receivable decreased 19% to $4.5 million, though Days Sales Outstanding (DSO) increased from 32 to 41 days. Accrued expenses dropped 47% following the payout of fiscal year 2025 incentive compensation.
Outlook, Risks, and Management Commentary
- Backlog: The company reported 127 open sales orders totaling $27.9 million, a slight decrease from $28.4 million the prior year. Management expects to recognize the majority of this backlog in the current fiscal year.
- Capital Expenditures: CapEx for the quarter was $185,000. The company has commitments for $2.75 million in capital expenditures over the next 12 months and is evaluating additional spending to expand capacity.
- Risks: Management highlights risks including reductions in customer capital budgets, changing product demand, increased competition, and technological advances that could reduce demand for current products. Natural disasters affecting demand are also noted as a risk factor.
- Forward-Looking Statements: The filing includes standard disclaimers that results for the quarter are not necessarily indicative of full-year results and that forward-looking statements involve uncertainties.
Key Facts for Investor Verification
- Verify the sustainability of the 44% revenue decline in the Asia region and the 26% decline in the aerospace/defense sector.
- Monitor the increase in Days Sales Outstanding (DSO) from 32 to 41 days to ensure collection trends do not worsen.
- Assess the impact of the $2.75 million committed capital expenditure on future cash flows and capacity utilization.
- Review the composition of the $27.9 million backlog to understand the timing of future revenue recognition.
- Confirm the status of the overdue structural project balance, which was reduced to $591,000 as of August 31, 2025.